Most articles on mass tort CTV explain what CTV is. This one doesn’t. If you’re reading this, you already run campaigns. What you want is the panel data on who’s actually spending, the platforms that move the needle, and the attribution stack that ties CTV impressions to signed retainers.
Here’s the short version. Linear TV is shrinking 14% a year. CTV is growing 11% a year and accelerating into 2026. The mass tort firms compounding their case volume aren’t outspending anyone. They’re the ones who wired the pixel correctly.
We track $150M+ in monthly legal ad spend across 3,720 advertisers in 210 DMAs. Mass tort is roughly a tenth of that category, and its channel mix is rotating faster than any other segment of legal. That’s the game in 2026.
The State of Mass Tort CTV in 2026
ATRA and X Ante tracked $2.5 billion in legal services advertising across 26.9 million ads in 2024. Mass tort made up a growing share of that, and the growth wasn’t in broadcast. Broadcast mass tort TV peaked at 16.4 million ads in 2023 and has been flat-to-declining since. The dollars moved. They didn’t disappear.
Which torts drive the spend? Camp Lejeune remains the anchor despite the MDL slowing down. NEC baby formula, hair relaxer, and PFAS/AFFF firefighting foam are the fastest-growing. Talc, Tylenol autism, Paragard, and Ozempic sit behind them. The common pattern: every one of these torts has a definable exposure profile that household-level data can isolate. Not perfectly. But well enough to beat broadcast on cost per qualifier.
The firms winning in this category aren’t the biggest. They’re the earliest to wire attribution. A single-market firm running $25K a month in CTV with a closed-loop pixel will out-signal a national broadcast buy that can’t prove a single case originated from a spot.
Mass Tort CTV Spend by Tort (Directional, 2025-2026)
| Mass Tort | CTV Activity | Targeting Basis |
|---|---|---|
| Camp Lejeune | High | Veteran-dense DMAs plus NC geographic overlay |
| NEC (baby formula) | High | Parents 25-45, NICU adjacency signals |
| Hair relaxer | High | Demographic + beauty purchase history |
| PFAS / AFFF | Rising | Water district overlays, firefighter retirees |
| Talc | Moderate | Adult women, personal care purchase data |
| Tylenol autism | Moderate | Parent segments, special education interest |
| Paragard IUD | Moderate | Women 18-45, reproductive health interest |
| Ozempic | Rising | GLP-1 interest, diabetes adjacency |
Directional from our panel. Exact spend varies by DMA, month, and media buyer.
Platform Breakdown: Where the Impressions Actually Come From
Not all CTV inventory is equal. The platform you buy on determines your CPM, your audience quality, and whether your pixel can fire. Here’s how the major players stack up for mass tort.
Roku. The biggest CTV device footprint in the US with roughly 80 million active accounts. Programmatic via The Trade Desk, DV360, and Roku’s OneView platform. CPMs typically $18 to $32 on run-of-network, higher on premium channels. Strong for broad mass tort reach. Weak for deep demographic layers compared to logged-in platforms.
Hulu (Disney Ads). Premium video inventory with logged-in user data. CPMs in the $35 to $55 range for legal. The reach is smaller but the audience is higher-intent and better-authenticated. Strong for narrative 30-second spots on torts with mass-market prevalence (Camp Lejeune, talc, Roundup). Disney Ads opened more programmatic inventory in 2025.
Samsung Ads. ACR (automatic content recognition) data lets you retarget households that saw a competing law firm broadcast spot. CPMs $20 to $35. Strong for head-to-head retargeting strategies. Samsung sits on roughly 50 million smart TVs in the US.
LG Ads. Similar ACR data. Native home screen placements. CPMs $18 to $30. Often the cheapest premium inventory in mass tort rotations.
Vizio (Inscape). ACR data plus viewership panels. Commonly paired with Innovid or LiveRamp for cross-platform measurement. CPMs $18 to $28.
YouTube CTV. The sleeper. YouTube on the TV screen now accounts for more watch time than any single streamer. CPMs $25 to $45 depending on targeting. Google’s audience layers (in-market, custom intent, demographic) stack with CTV-specific formats. Strong for qualifier-question pre-roll at the top of the funnel.
Amazon Fire TV / Prime Video. Prime Video ads launched in 2024 and opened significant inventory. Amazon DSP lets you layer first-party shopping data for behaviorally adjacent torts (household cleaning products, personal care, supplements). CPMs $25 to $45. Strong for torts with a consumer-product exposure profile.
Programmatic Access
The mass tort CTV buys that scale efficiently go through a DSP, not an IO. The Trade Desk and DV360 are the dominant paths. Amazon DSP for Fire TV / Prime Video inventory. Innovid for unified cross-platform attribution and served-ad verification. One firm per market. No duplicative bidding inside your own DMA.
Audience Targeting: The Actual Methods
This is where most CTV vendor articles fall apart. They say “advanced targeting” and move on. Here’s what the targeting stack actually looks like for a live mass tort CTV campaign.
Health condition adjacency. Acxiom, Experian, and TransUnion maintain health-interest segments compiled from survey, purchase, and declared interest data. These aren’t HIPAA-protected medical records. They’re consumer health-interest signals: who buys supplements, who searches for symptoms, who subscribes to condition-specific publications. For NEC you layer “premature infant parent” segments. For hair relaxer you layer demographic plus beauty-product purchase history. For Tylenol autism you layer parent segments plus special education interest signals.
CRM-match lookalikes. This is the underused lever. Take your existing qualified-claimant seed list (not a full retainer list, just qualifiers from a past tort). Upload it to LiveRamp or the DSP’s identity partner. Build a lookalike audience on household identifiers. For Camp Lejeune that might be a seed of 8,000 qualifiers producing a 4 million household lookalike across CTV inventory. Higher qualifier density per impression than any behavioral segment.
Geographic exposure overlays. Camp Lejeune by base proximity and veteran density. PFAS by EPA-identified contamination zones and water district boundaries. AFFF by firefighter retiree concentration. Talc by older adult female density. The geography isn’t broad DMA targeting. It’s zip-plus-four polygons layered over your demographic base.
Qualifier-question pre-roll. Short 6 to 15 second pre-roll that leads with the qualifier question (“Did you serve at Camp Lejeune between 1953 and 1987?”) and lets non-qualifiers self-select out. Typically used early in the funnel to build a retargeting pool. Higher CPM on a short-duration unit, lower waste down-funnel.
30-second narrative spots. The deeper-funnel unit. Named plaintiffs or documentary-style case context, settlement range with disclaimers, clear call path. Use on retargeted households that already saw the pre-roll or a search ad. The cost per qualifier drops by 2-4x when the 30-second airs to a warm audience.
The layering matters. A cold 30-second on run-of-network CTV is broadcast with a better pixel. A 15-second qualifier pre-roll feeding a 30-second narrative retarget through Innovid is a campaign.
Creative Framework: What Actually Moves Qualifiers
Taqtics uses a five-scene emotional arc on mass tort CTV: recognition, diagnosis, isolation, validation, action. Full breakdown lives in the creative production framework but the short version is this. The plaintiff recognizes themselves in the ad. The ad confirms the condition and the exposure link. It names the betrayal of trust. It validates their standing. It ends with a clear, compliant call path.
What works on CTV mass tort creative:
- Named plaintiffs or documentary-style case context
- Case timeline shown clearly (exposure window, diagnosis, settlement status)
- Settlement ranges with mandatory disclaimers
- Qualifier questions at end, not at open
- Voice-over that sounds like a local anchor, not a pitchman
What kills conversion:
- Gavel shots and scales-of-justice stock footage
- “Fighting for you” boilerplate
- Generic aggressive attorney on-camera 30-seconds
- Any ad that could run for any mass tort with a logo swap
The creative commodity problem is real. If your ad can be pattern-matched to 15 other firms running the same tort, you’re paying for mindshare you won’t capture. One firm per market discipline extends to creative. Differentiated spot, differentiated pixel, differentiated closed loop.
Attribution Architecture: The Part Nobody Writes About
This is where the article exists. Most SERP competitors stop at “CTV has better measurement.” Here’s the actual stack that ties a CTV impression to a signed retainer.
Step 1. Impression to household ID. The DSP fires an ad on a CTV device. That impression is logged against a household identifier: Innovid’s Household Graph, LiveRamp’s RampID, TransUnion’s TruAudience, or the platform’s native ID (Roku ID, Samsung CDP). The household is the unit, not the device.
Step 2. Household to web session. When anyone in that household later visits your firm’s website (or the intake landing page), the same identity graph matches the web session back to the CTV-exposed household. This is the “view-through” join. LiveRamp’s authenticated traffic network and Innovid’s IDA platform handle this on the server side.
Step 3. Web session to call. Call tracking (Callrail, Invoca, CallTrackingMetrics) captures the inbound call, the landing page, the referring source. Dynamic number insertion ties the call back to the specific campaign and household.
Step 4. Call to qualifier. Intake team runs the call through the qualifier script. Filevine, Litify, or CloudLex logs the call as qualified or not. Roughly 15 to 40% of calls qualify on a well-targeted mass tort campaign. Higher on torts with pre-roll qualifier filtering, lower on broad demo layers.
Step 5. Qualifier to signed retainer. Signed contracts log back against the same lead record. Typical conversion from qualifier to signed is 30 to 60% depending on tort, geography, and intake quality.
Step 6. Signed event back to DSP. The Conversion API sends the signed-case event back to The Trade Desk, DV360, or Amazon DSP as a high-value conversion. The DSP’s bid model now optimizes toward households that resemble your signed-case profile, not your click profile. Within 4 to 8 weeks the campaign is optimizing on retainer signal, not impression signal.
Broadcast can’t do any of this. The impression dies when it airs. You’re paying for reach and guessing at attribution through post-hoc call volume. That math was acceptable when CTV wasn’t an option. It isn’t acceptable now.
Compliance and Guardrails
State bar rules on mass tort solicitation are tightening, not loosening. ABA Model Rule 7.3 governs solicitation generally and most states have adopted some version. Mass tort CTV ads must clearly identify themselves as advertisements, name the responsible attorney or firm, and avoid any promise of specific outcome.
California’s SB 37 (covered in our California SB 37 compliance briefing) adds personal injury-specific rules that reach into CTV creative. Specific settlement claims require substantiation. Medical advice language is restricted. FTC oversight on consumer-health claims has increased for CTV specifically because the measurement infrastructure lets regulators verify what aired where.
Mandatory compliance baseline for mass tort CTV creative:
- “Advertising material” or “This is an advertisement” disclosure
- Named responsible attorney or firm with bar jurisdiction
- Settlement range qualifiers: “Past results do not guarantee future outcomes”
- No medical advice. Use “may qualify for” not “you have”
- MDL-specific language aligned with active court orders
- State-specific disclaimers where bar rules require them
Run every spot through outside compliance review before uploading to any DSP. Platforms reject creative faster than they used to, and a rejection during a media flight costs more than the legal review did.
The Scorecard: When CTV Is Worth It for a Mass Tort
Not every mass tort justifies CTV. Here’s the framework we use on our panel.
Qualifier prevalence. If the qualifying condition or exposure profile affects less than 0.01% of the population (mesothelioma at roughly 3,000 diagnoses per year across 131 million US households), CTV’s advantage is attribution, not targeting. You still run it, but only with a closed-loop stack that justifies the 99%+ non-qualifying impression rate. If prevalence is above 0.1% (Roundup, PFAS, hair relaxer), CTV’s targeting layers meaningfully concentrate spend 3-5x over broadcast.
Budget floor. $20K per DMA per month is the honest minimum to hit household reach frequency that moves the attribution needle. Below that you’re testing, not scaling. Under $10K per month per market, run search and programmatic display. CTV needs frequency and frequency needs budget.
Case value threshold. Expected settlement value needs to clear 20x the cost per signed case for the math to work. For most active mass torts that’s trivial. For emerging torts with uncertain settlement ranges, model conservatively.
Attribution maturity. If you can’t wire Steps 1-6 above, CTV will look underperforming on dashboard metrics because the dashboard can’t see the signed cases. Fix attribution before you scale spend. A mature stack at $30K per DMA outperforms an unmeasured stack at $100K per DMA.
Short-Term vs Compound Play
SEO takes three to six months to rank on a mass tort keyword. Broadcast TV is cost-prohibitive for most single-firm mass tort plays and offers no attribution. Paid search has ceiling CPCs above $200 on active mass tort terms, with 47 firms bidding on the same Camp Lejeune keywords at any given time.
CTV is the channel that compounds. Impression, household, call, qualifier, retainer, conversion signal, better bid. Every week the campaign runs with closed-loop attribution, the bid model gets smarter. Every case signed feeds the next impression’s targeting.
Not every mass tort firm should run CTV. The ones that should have three things. A defensible market position (one firm per DMA discipline). An active mass tort they can fund at $20K+ per DMA per month. An attribution stack that traces impressions to signed cases.
If all three are in place, the channel is unambiguous. Cross-channel ROI measurement for law firms starts with CTV because CTV is the only channel where every step is measurable end-to-end.
The mass tort firms retaking ground in 2026 aren’t outspending anyone. They’re compounding. CTV is the channel where compounding happens.
References
- American Tort Reform Association and X Ante. "Legal Services Advertising in the United States, 2017-2024." March 2025.
- Interactive Advertising Bureau. "IAB Forecasts 13.8% US CTV Ad Spend Growth for 2026." December 2025.
- eMarketer. "Marketers Shift TV Ad Spending as Time with CTV Grows While Linear Declines." 2025.
- Bloomberg Law. "Camp Lejeune Ads Surge Amid Wild West of Legal Finance, Tech." 2023.
- AdvaMed and X Ante. "Medical Device Mass Tort TV Ad Trends Q1 2024." April 2024.
- Insurance Information Institute. "State of the Risk: Legal System Abuse." May 2025.
- American Bar Association. "Model Rule 7.3: Solicitation of Clients."
- MediaPost. "IAB 2026 Ad Spend Forecast: CTV +13.8%, Social +14%." December 2025.
